|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 181.15 SEK | -0.41% |
|
-4.05% | -32.82% |
| 11-29 | Di: These seven hard-to-get stocks to buy according to the experts | FW |
| 11-28 | Stockholm Bullets - Lindab implements savings program, new share issue in Klarabo after acquisition | FW |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions on site
| Capitalization | 16.08B 1.46B 1.39B 1.29B 1.15B 2.05B 124B 2.25B 5.96B 50.69B 5.48B 5.36B 218B | P/E ratio 2024 * |
-72.3x | P/E ratio 2025 * | 50.9x |
|---|---|---|---|---|---|
| Enterprise value | 15.2B 1.38B 1.31B 1.22B 1.09B 1.94B 117B 2.13B 5.63B 47.92B 5.18B 5.07B 206B | EV / Sales 2024 * |
60.5x | EV / Sales 2025 * | 15.6x |
| Free-Float |
44.08% | Yield 2024 * |
-
| Yield 2025 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: BioArctic AB
More recommendations
More press releases
More news
| 1 day | +0.19% | ||
| 1 week | -4.05% | ||
| Current month | -6.84% | ||
| 1 month | +25.37% | ||
| 3 months | +7.15% | ||
| 6 months | -25.97% | ||
| Current year | -32.82% |
1 week
176.50
197.80
1 month
137.70204.00
Current year
137.70288.40
1 year
137.70288.40
3 years
66.70392.00
5 years
47.00392.00
10 years
20.40392.00
| Director | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 31/12/2012 | |
| Director of Finance/CFO | 53 | 31/05/2023 | |
Johanna Fälting
CTO | Chief Tech/Sci/R&D Officer | 52 | 31/12/2011 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 77 | 23/01/2003 | |
| Chairman | 75 | 27/01/2003 | |
Eugen Steiner
CHM | Chairman | 70 | 31/05/2023 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.25% | 4 M€ | +19.51% | ||
| 0.19% | 2 M€ | -.--% | ||
| 0.07% | 7 M€ | -.--% | - | |
| 0.01% | 10 M€ | -3.35% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| +0.08% | -4.05% | -22.52% | +63.25% | 1.46B | ||
| +0.25% | +1.62% | +59.16% | -25.60% | 42.79B | ||
| -0.60% | -0.32% | -7.53% | -23.35% | 36.41B | ||
| +1.25% | +6.44% | +14.59% | -5.81% | 27.1B | ||
| -0.27% | +0.40% | -20.92% | -21.93% | 17.58B | ||
| -3.80% | +1.26% | -46.66% | -86.12% | 16.39B | ||
| -0.36% | -2.18% | +53.20% | +98.28% | 16.46B | ||
| -1.28% | +0.24% | +16.23% | -34.19% | 11.92B | ||
| -0.90% | +1.21% | +23.19% | +64.58% | 10.52B | ||
| -0.97% | +0.78% | -1.18% | -44.23% | 10.19B | ||
| Average | -0.08% | -0.18% | +6.76% | -1.51% | 19.08B | |
| Weighted average by Cap. | +0.14% | +0.40% | +14.62% | -12.41% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 251M 22.81M 21.7M 20.21M 18.01M 32.09M 1.93B 35.22M 93.17M 792M 85.7M 83.78M 3.41B | 973M 88.3M 84M 78.24M 69.74M 124M 7.48B 136M 361M 3.07B 332M 324M 13.2B |
| Net income | -223M -20.22M -19.24M -17.92M -15.97M -28.45M -1.71B -31.23M -82.61M -703M -75.99M -74.29M -3.02B | 288M 26.16M 24.88M 23.18M 20.66M 36.8M 2.22B 40.4M 107M 909M 98.29M 96.09M 3.91B |
| Net Debt | -878M -79.67M -75.79M -70.6M -62.93M -112M -6.75B -123M -325M -2.77B -299M -293M -11.91B | -943M -85.6M -81.44M -75.86M -67.61M -120M -7.25B -132M -350M -2.97B -322M -314M -12.8B |
More financial data
* Estimated data
Employees
104
Calendar
13/02/2025
- Q4 2024 Earnings Release
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/12/24 | 179.90 kr | -1.10% | 115,062 |
| 03/12/24 | 181.90 kr | -6.09% | 521,699 |
| 02/12/24 | 193.70 kr | +0.31% | 164,413 |
| 29/11/24 | 193.10 kr | 0.00% | 335,042 |
| 28/11/24 | 193.10 kr | +2.99% | 135,090 |
Delayed Quote Nasdaq Stockholm, December 04, 2024 at 10:00 am
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
181.90SEK
Average target price
322.00SEK
Spread / Average Target
+77.02%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BIOA B Stock
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition